About the Authors
- Ulrika Johansson
-
Affiliations Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, the Biomedical Centre, S-750 07, Uppsala, Sweden, The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, S-171 76 Stockholm, Sweden
- Massimiliano Ria
-
Contributed equally to this work with: Massimiliano Ria, Karin Åvall
Affiliation The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, S-171 76 Stockholm, Sweden
- Karin Åvall
-
Contributed equally to this work with: Massimiliano Ria, Karin Åvall
Affiliation The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, S-171 76 Stockholm, Sweden
- Nancy Dekki Shalaly
-
Affiliation Division of Protein Technology, School of Biotechnology, KTH Royal Institute of Technology, S-106 91 Stockholm, Sweden
- Sergei V. Zaitsev
-
* E-mail: My.Hedhammar@slu.se (MH); Sergei.Zaitsev@ki.se (SVZ)
Affiliation The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, S-171 76 Stockholm, Sweden
- Per-Olof Berggren
-
Affiliation The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, S-171 76 Stockholm, Sweden
- My Hedhammar
-
* E-mail: My.Hedhammar@slu.se (MH); Sergei.Zaitsev@ki.se (SVZ)
Affiliations Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, the Biomedical Centre, S-750 07, Uppsala, Sweden, Division of Protein Technology, School of Biotechnology, KTH Royal Institute of Technology, S-106 91 Stockholm, Sweden
Competing Interests
The authors have read the journal's policy and the authors of this manuscript have the following competing interests: MH has shares in Spiber Technologies AB, a company that aims to commercialize recombinant spider silk. POB is the founder of the Biotech Company Biocrine AB and is also a member of the board of this company. SZ is a consultant for Biocrine AB. POB and MH are members of the board of Betamatrix, a company jointly owned by Spiber Technologies AB and Biocrine AB. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: UJ SZ POB MH. Performed the experiments: UJ MR KÅ NDS MH. Analyzed the data: UJ MR KÅ NDS SZ MH. Wrote the paper: UJ POB MH.